Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Lipton

Showing results (11-20 of 148) with videos related to

Pageof 15
Sort By:
Seminars in Oncology|November 30, 2010
Implications of bone metastases and the benefits of bone-targeted therapyAllan Lipton
Current Oncology Reports|November 6, 2010
Denosumab in breast cancerAllan Lipton
Breast Cancer Research and Treatment|May 22, 2010
Should bisphosphonates be utilized in the adjuvant setting for breast cancer?Allan Lipton
Expert Opinion on Emerging Drugs|December 10, 2003
Bisphosphonate therapy in the oncology settingAllan Lipton
Expert Review of Anticancer Therapy|August 3, 2011
Zoledronic acid: multiplicity of use across the cancer continuumAllan Lipton
American Journal of Clinical Oncology|June 8, 2010
Bone continuum of cancerAllan Lipton
Expert Opinion on Pharmacotherapy|January 21, 2011
Improving progression-free and overall survival in patients with cancer: a potential role for bisphosphonatesAllan Lipton
Breast Cancer (Dove Medical Press)|December 25, 2013
Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancerAllan Lipton
Cancer Treatment Reviews|May 20, 2008
Emerging role of bisphosphonates in the clinic--antitumor activity and prevention of metastasis to boneAllan Lipton
Current Treatment Options in Oncology|February 22, 2003
Bone metastases in breast cancerAllan Lipton
Pageof 15

Showing results (11-20 of 148) with videos related to

Sort By:
Pageof 15
Seminars in Oncology|November 30, 2010
Implications of bone metastases and the benefits of bone-targeted therapyAllan Lipton
Current Oncology Reports|November 6, 2010
Denosumab in breast cancerAllan Lipton
Breast Cancer Research and Treatment|May 22, 2010
Should bisphosphonates be utilized in the adjuvant setting for breast cancer?Allan Lipton
Expert Opinion on Emerging Drugs|December 10, 2003
Bisphosphonate therapy in the oncology settingAllan Lipton
Expert Review of Anticancer Therapy|August 3, 2011
Zoledronic acid: multiplicity of use across the cancer continuumAllan Lipton
American Journal of Clinical Oncology|June 8, 2010
Bone continuum of cancerAllan Lipton
Expert Opinion on Pharmacotherapy|January 21, 2011
Improving progression-free and overall survival in patients with cancer: a potential role for bisphosphonatesAllan Lipton
Breast Cancer (Dove Medical Press)|December 25, 2013
Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancerAllan Lipton
Cancer Treatment Reviews|May 20, 2008
Emerging role of bisphosphonates in the clinic--antitumor activity and prevention of metastasis to boneAllan Lipton
Current Treatment Options in Oncology|February 22, 2003
Bone metastases in breast cancerAllan Lipton
Pageof 15